论文部分内容阅读
目的评价恶性危险指数Ⅱ(RM IⅡ)在卵巢肿瘤早期诊断中应用的临床价值,探讨卵巢恶性肿瘤的早期诊断方法。方法对152例住院手术的卵巢肿瘤患者,分别计算患者绝经状态、超声评分、术前血清CA125值及RM IⅡ。对卵巢良、恶性的情况进行预测,并比较其敏感性、特异性、阳性预测值、阴性预测值。结果 RM IⅡ诊断卵巢恶性肿瘤的敏感性、特异性、阳性预测值、阴性预测值高于其他的检查方法。结论 RM IⅡ在早期诊断卵巢恶性肿瘤,特别是恶性上皮性肿瘤上具有重要意义。但在诊断卵巢恶性肿瘤Ⅰ期、卵巢交界性肿瘤中尚有局限性。
Objective To evaluate the clinical value of RM Ⅱ in the early diagnosis of ovarian tumors and to explore the early diagnosis of ovarian malignant tumors. Methods Fifty-two patients with ovarian cancer who underwent in-hospital surgery were enrolled in the study. Their postmenopausal status, ultrasound score, preoperative serum CA125 value and RM IⅡ were calculated. Predict the benign and malignant ovarian conditions and compare their sensitivity, specificity, positive predictive value and negative predictive value. Results The sensitivity, specificity, positive predictive value and negative predictive value of RM I II in the diagnosis of ovarian cancer were higher than those of other test methods. Conclusion RM I Ⅱ is of great importance in the early diagnosis of ovarian cancer, especially malignant epithelial tumors. However, in the diagnosis of ovarian cancer stage Ⅰ, borderline ovarian cancer there are limitations.